LIPELLA PHARMACEUTICALS INC. Net Income Loss

Quick Answer

LIPELLA PHARMACEUTICALS INC. reported Net Income Loss of -$5.02 million for the year ending 2024.

  • LIPELLA PHARMACEUTICALS INC. showed a decrease of -8.6% in Net Income Loss from 2023 to 2024.
  • This data is from LIPELLA PHARMACEUTICALS INC.'s annual report (Form 10-K), filed with the SEC on March 28, 2025.
  • XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2021 to 2024), LIPELLA PHARMACEUTICALS INC.'s Net Income Loss has declined by 168.9%.
  • Historical annual values: Fiscal year 2024: -$5.02 million | Fiscal year 2023: -$4.62 million | Fiscal year 2022: -$2.60 million | Fiscal year 2021: -$1.87 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: